港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

抗疫概念

938.683

-0.060-0.01%

漲家數：7

跌家數：11

平家數：- -

市盈率：- -

高：961.843

開：939.153

低：926.987

收：938.742

資料載入中...

《大行》里昂：京東健康(06618.HK)受惠“雙十一”及流感料去年下半年收入升13%

阿斯达克财经

京東健康(06618)漲3.05% 成立“JDH+N”助聽器品牌聯盟

港股異動 | 京東健康(06618)盤中漲超5% 宣佈聯合多個聽力行業品牌成立“JDH+N”助聽器品牌聯盟

同源康醫藥-B盤中異動早盤大幅下挫5.63%報30.200港元

京東健康-R盤中異動股價大漲4.31%

歌禮制藥-B盤中異動早盤股價大漲5.00%報7.560港元

比亞迪電子盤中異動早盤快速上漲3.00%

京東健康盤中異動早盤急速拉昇3.05%報37.150港元

近四年港股最大規模融資，配股435億港元，暗藏比亞迪的全球野望

Ofweek维科网

復星醫藥(02196.HK)24價肺炎球菌多糖結合疫苗於中國獲批臨牀試驗

阿斯达克财经

比亞迪智電領航，破浪前行

復星醫藥子公司疫苗獲批臨牀；葫蘆娃聘任新總經理丨醫藥早參

每日经济新闻

凱西醫藥諮詢（上海）有限公司申請II類會議

比亞迪H股閃電配售共融資433.83億港元，為近10年來汽車行業規模最大股權再融資項目

歌禮制藥-B(1672.HK)：早期臨牀研發取得突破 GLP1口服藥物值得關注

中信建投证券

港交所與迅清結算簽署合作備忘錄；比亞迪募集擬435億港元用於海外擴張等丨港交所早參

每日经济新闻

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1515/news?page=14"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":938.6827,"timestamp":1741594084356,"preClose":938.7422,"halted":0,"volume":561548394,"delay":0,"changeRate":-0.000063,"change":-0.059509,"pbRate":1.645833,"amount":5108738946,"amplitude":0.037131,"prevYearClose":787.97723,"fiveDayClose":910.428,"twentyDayClose":879.539,"turnoverRate":0.007459,"marketCap":648160563744,"floatMarketCap":532164049056,"peRate":19.918974},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":961.84296,"amplitude":0.037131,"preClose":938.7422,"low":926.9865,"pbRate":"1.645833","latestPrice":938.6827,"volume":561548394,"delay":0,"open":939.1531,"prevYearClose":787.97723,"prevWeekClose":938.742,"prevMonthClose":904.791,"prevQuarterClose":787.977,"fiveDayClose":910.428,"twentyDayClose":879.539,"sixtyDayClose":794.849,"secType":"PLATE","market":"HK","turnoverRate":0.007459,"peRate":19.918974,"marketCap":648160563744,"floatMarketCap":532164049056,"timestamp":1741594084356,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":7,"down":11,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:16,pageCount:14,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517958322","title":"《大行》里昂：京東健康(06618.HK)受惠“雙十一”及流感  料去年下半年收入升13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517958322","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517958322?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 10:22","pubTimestamp":1741141320,"startTime":"0","endTime":"0","summary":"里昂报告预测，京东健康去年下半年业绩稳固，收入按年升13%至297亿元人民币，受惠“双十一”良好表现及去年12月流感感染增加。受惠毛利率扩张，经调整EBIT料按年升23%至12亿元人民币。该行料公司去年下半年直接销售按年升12%至253亿元人民币，其中第四季按年升11%，年活跃用户料较上半年增加900万至1.9亿，但平均订单价值将继续下跌，因消费情绪平淡及免运费门槛下降。该行维持对京东健康“跑赢大市”评级，目标价40元。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240924144113511_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240924144113511_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1422230/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1571","BK1589","06618","BK1247","86618","LU0456827905.SGD","LU0051755006.USD","BK1591","BK1583","BK1515","BK1142"],"gpt_icon":0},{"id":"2517484937","title":"京東健康(06618)漲3.05% 成立“JDH+N”助聽器品牌聯盟","url":"https://stock-news.laohu8.com/highlight/detail?id=2517484937","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517484937?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 10:03","pubTimestamp":1741140225,"startTime":"0","endTime":"0","summary":"金吾财讯 | 京东健康 股价走高，截至发稿，涨3.05%，报37.15港元，成交额2.03亿港元。消息面上，3月4日，京东健康宣布携手WSA、科大讯飞、挚听、可孚、奥迪康等多个听力行业品牌，成立“JDH+N”助听器品牌联盟。统计数据显示，2024年京东健康助听器类商品的总交易额同比增长超过30%，用户规模增长超过40%，其中超八成的交易是子女为家中老人选购助听器。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954370","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1571","86618","LU0456827905.SGD","BK1589","BK1591","LU0051755006.USD","BK1142","06618","BK1247","BK1583"],"gpt_icon":0},{"id":"2517932959","title":"港股異動 | 京東健康(06618)盤中漲超5% 宣佈聯合多個聽力行業品牌成立“JDH+N”助聽器品牌聯盟","url":"https://stock-news.laohu8.com/highlight/detail?id=2517932959","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517932959?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 09:49","pubTimestamp":1741139376,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，京东健康盘中涨超5%，截至发稿，涨3.47%，报37.35港元，成交额1.74亿港元。据统计，2024年京东健康助听器类商品的总交易额按年增长超过30%，用户规模增长超过40%，其中八成以上交易是子女为家中老人选购助听器。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257823.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 京东健康(06618)盘中涨超5% 宣布联合多个听力行业品牌成立“JDH+N”助听器品牌联盟","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1571","BK1583","06618","BK1589","BK1591","BK1142","LU0456827905.SGD","BK1247","86618","LU0051755006.USD"],"gpt_icon":0},{"id":"2517093250","title":"同源康醫藥-B盤中異動 早盤大幅下挫5.63%報30.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517093250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517093250?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 09:42","pubTimestamp":1741138937,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时42分，同源康医药-B股票出现异动，股价急速下跌5.63%。截至发稿，该股报30.200港元/股，成交量2.85万股，换手率0.01%，振幅10.31%。资金方面，该股资金流入6.6225万港元，流出68.6275万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，康宁杰瑞制药-B、和誉-B、再鼎医药涨幅较大，振幅较大的相关个股有同源康医药-B、康宁杰瑞制药-B、和誉-B，振幅分别为9.38%、9.16%、8.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503050942179639f689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503050942179639f689&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","02410","BK1574","BK1515"],"gpt_icon":0},{"id":"2517932981","title":"京東健康-R盤中異動 股價大漲4.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517932981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517932981?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 09:39","pubTimestamp":1741138779,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时39分，京东健康-R股票出现异动，股价快速上涨4.31%。截至发稿，该股报35.100港元/股，成交量550股，换手率0.00%，振幅1.78%。京东健康-R股票所在的药品分销行业中，整体涨幅为0.17%。其相关个股中，京东健康、京东健康-R、药师帮涨幅较大，振幅较大的相关个股有满贯集团、京东健康、药师帮，振幅分别为4.03%、4.02%、3.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503050939399639f58c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503050939399639f58c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1247","LU0456827905.SGD","BK1583","LU0051755006.USD","06618","BK1589","BK1515","BK1142","BK1591","86618","BK1571"],"gpt_icon":0},{"id":"2517932590","title":"歌禮制藥-B盤中異動 早盤股價大漲5.00%報7.560港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517932590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517932590?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 09:39","pubTimestamp":1741138743,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时39分，歌礼制药-B股票出现波动，股价大幅拉升5.00%。截至发稿，该股报7.560港元/股，成交量41.2万股，换手率0.04%，振幅4.86%。歌礼制药-B股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，康宁杰瑞制药-B、再鼎医药、科笛-B涨幅较大，振幅较大的相关个股有康宁杰瑞制药-B、科笛-B、和誉-B，振幅分别为7.63%、7.59%、7.42%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093903a25fc2bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093903a25fc2bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","01672","BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2517478934","title":"比亞迪電子盤中異動 早盤快速上漲3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517478934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517478934?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 09:36","pubTimestamp":1741138584,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时36分，比亚迪电子股票出现异动，股价快速拉升3.00%。截至发稿，该股报49.800港元/股，成交量79.8126万股，换手率0.04%，振幅1.55%。机构评级方面，在所有18家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。比亚迪电子股票所在的电讯设备行业中，整体涨幅为0.77%。比亚迪电子公司简介：比亚迪电子(国际)有限公司是一家主要制造移动智能终端部件及模组的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093624989c59a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093624989c59a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348767384.USD","BK1515","BK1580","BK1607","BK1540","BK1589","BK1582","LU0348766576.USD","LU0274383008.USD","00285","BK1504","BK1149"],"gpt_icon":0},{"id":"2517932612","title":"京東健康盤中異動 早盤急速拉昇3.05%報37.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517932612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517932612?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 09:32","pubTimestamp":1741138376,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时32分，京东健康股票出现波动，股价快速上涨3.05%。截至发稿，该股报37.150港元/股，成交量111.467万股，换手率0.03%，振幅2.91%。资金方面，该股资金流入2689.21万港元，流出669.212万港元。京东健康股票所在的药品分销行业中，整体涨幅为0.27%。其相关个股中，京东健康、京东健康-R、阿里健康涨幅较大，振幅较大的相关个股有京东健康、国药控股、阿里健康，振幅分别为2.64%、1.75%、1.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093256989c57ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093256989c57ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1571","BK1583","06618","BK1589","BK1591","BK1142","LU0456827905.SGD","BK1247","86618","LU0051755006.USD"],"gpt_icon":0},{"id":"2517311339","title":"近四年港股最大規模融資，配股435億港元，暗藏比亞迪的全球野望","url":"https://stock-news.laohu8.com/highlight/detail?id=2517311339","media":"Ofweek维科网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517311339?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 09:29","pubTimestamp":1741138145,"startTime":"0","endTime":"0","summary":"若配售股份全部成功配售，预计所得款项总额约达435.09亿港元，扣除佣金及预估费用后，所得款项净额预计约为433.83亿港元。此次配售，比亚迪共计发行1.298亿股新H股，这一数量占现有已发行H股的约11.82%，占已发行股份总数的约4.46%。配售折价以及股本稀释等因素相互交织，致使比亚迪港股在开盘当日，市值便大幅蒸发超300亿港元。此次融资或许将成为比亚迪估值体系重构过程中的重要分水岭。原文标题 : 近四年港股最大规模融资，配股435亿港","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503050929159639efde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503050929159639efde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828631.EUR","LU1868838027.USD","BK1610","BYDDY","002594","LU0449509016.USD","LU0588546209.SGD","LU0593848301.USD","LU0516423091.SGD","HYDD.SI","LU0143863784.USD","81211","LU0348735423.USD","LU0143863198.USD","LU2097828805.USD","LU2097828474.EUR","LU2153592121.USD","LU0289961442.SGD","HSTECH","LU0289739343.SGD","LU0211977185.USD","BK1522","LU0516423174.USD","LU0164872284.USD","LU0516422366.SGD","LU0289960550.SGD","01211","LU1808992512.USD","BK1589","LU0819123356.HKD","LU0979878070.USD","LU2348774022.SGD","SG9999006514.SGD","LU1861214812.USD","00285","LU0348766576.USD","BK1515","HSCEI","LU2778985437.USD","LU1868837565.USD","LU1242518857.USD","LU0052750758.USD","SG9999006597.SGD","LU0359201612.USD","BK1582","BK1504","BK1594","LU0359202008.SGD","LU0531970944.HKD"],"gpt_icon":1},{"id":"2517202936","title":"復星醫藥(02196.HK)24價肺炎球菌多糖結合疫苗於中國獲批臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2517202936","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517202936?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 08:24","pubTimestamp":1741134240,"startTime":"0","endTime":"0","summary":"复星医药(02196.HK) 公布，旗下控股子公司复星安特金(成都)生物制药，于近日收到国家药监局关于24价肺炎球菌多糖结合疫苗的临床试验批准。复星安特金(成都)生物制药拟于条件具备后于中国境内开展该疫苗的I期临床试验。据介绍，该疫苗为复星医药自主研发的预防用生物制品，拟用于预防由肺炎球菌血清型引起的感染性疾病。截至今年1月，复星医药现阶段针对该疫苗的累计研发投入约为4,400万元人民币。另外，截至周二(4日)，于全球范围内尚无24价肺炎球菌多糖结合疫苗获批上市。(js/k)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-04 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220221174705869_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220221174705869_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1422161/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0183","BK0096","BK0196","600196","BK0188","03347","BK1515","BK0187","159646","BK0028","BK1576","BK0012","BK1141","BK0239","BK1583","BK1191","BK1593","02196","BK0175","BK0060"],"gpt_icon":0},{"id":"2517936231","title":"比亞迪智電領航，破浪前行","url":"https://stock-news.laohu8.com/highlight/detail?id=2517936231","media":"东吴证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517936231?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 08:15","pubTimestamp":1741133730,"startTime":"0","endTime":"0","summary":"比亚迪2月发布天神之眼C，10万以上全系标配，实现加配不加价，叠加老款促销力度加大，带动2月销量环比向上。结构方面，比亚迪2月本土销量25.6万辆，同增164%，海外销6.7万辆，同增188%，高端销量1.35万辆，同增76%，出口+高端化进一步贡献增量。比亚迪2月累计装机16.7GWh，同环比+150%/+8%，二代刀片发布在即，续航+快充有望全面提升。比亚迪25年累计装机32.2GWh，同增79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305084815abe89b1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305084815abe89b1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828631.EUR","BK1610","BYDDY","LU0274383008.USD","BK1149","LU0348805143.USD","LU0516422440.USD","002594","LU0588546209.SGD","BK1539","LU0823426308.USD","LU2097828714.EUR","LU0516423091.SGD","HYDD.SI","LU2476274308.USD","LU1242518931.SGD","LU0143863784.USD","81211","LU0348735423.USD","LU0289961442.SGD","SG9999014674.SGD","LU0054450605.USD","LU0320764599.SGD","IE00BD6J9T35.USD","SG9999001226.SGD","LU0175139822.USD","LU1868837722.USD","LU0516422366.SGD","01211","LU2249611893.SGD","BK1589","LU0819123356.HKD","LU2348774022.SGD","LU2360107325.USD","LU0417516738.SGD","LU2097828557.USD","LU1861214812.USD","00285","LU0348766576.USD","BK1515","LU0254981946.USD","LU0856984785.SGD","LU1023057109.AUD","LU1868837565.USD","LU2778985437.USD","LU0511384066.AUD","BK1509","LU1861219969.SGD","BK1504","LU0531970944.HKD"],"gpt_icon":1},{"id":"2517336859","title":"復星醫藥子公司疫苗獲批臨牀；葫蘆娃聘任新總經理丨醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2517336859","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517336859?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 07:56","pubTimestamp":1741132577,"startTime":"0","endTime":"0","summary":"丨2025年3月5日星期三丨NO.1复星医药子公司疫苗获批临床复星医药控股子公司复星安特金（成都）生物制药有限公司于近日收到国家药品监督管理局关于24价肺炎球菌多糖结合疫苗的临床试验批准。复星安特金拟于条件具备后开展该疫苗的I期临床试验。点评：截至本公告披露日，全球范围内尚无24价肺炎球菌多糖结合疫苗获批上市。该疫苗有望进一步丰富肺炎预防产品线，提升公司在疫苗领域的竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503053336603395.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503053336603395.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1191","BK1161","BK1515","02196","09939","BK1593"],"gpt_icon":0},{"id":"2517385989","title":"凱西醫藥諮詢（上海）有限公司申請II類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2517385989","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517385989?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 07:18","pubTimestamp":1741130281,"startTime":"0","endTime":"0","summary":"金融界3月5日消息，据CDE官网沟通交流公示，于3月5日收到凯西医药咨询 有限公司申请的“II类会议”，当前状态“处理中”。凯西医药咨询（上海）有限公司，成立于2008年，位于上海市，是一家以从事商务服务业为主的企业。通过天眼查大数据分析，凯西医药咨询（上海）有限公司拥有行政许可15个。主要股东信息显示，凯西医药咨询（上海）有限公司由CHIESI FARMACEUTICI S.P.A.持股100%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/05071848524691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","159938","BK1515","09939","BK1161"],"gpt_icon":0},{"id":"2517784601","title":"比亞迪H股閃電配售 共融資433.83億港元，為近10年來汽車行業規模最大股權再融資項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2517784601","media":"深圳商报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517784601?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 01:10","pubTimestamp":1741108234,"startTime":"0","endTime":"0","summary":"【深圳商报讯】（记者周良成）3月3日盘后，比亚迪宣布完成了一项规模达433.83亿港元（约56亿美元）的港股闪电配售，成为近10年来全球汽车行业规模最大的股权再融资项目，也是全球汽车行业有史以来规模最大的闪电配售项目。据了解，配售是港股市场再融资手段之一，配售股份不超20%，董事会提前获得股东大会授权后，可择机进行，“闪电配售”机制可在一天内完成资金募集，满足企业快速融资需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503053336387792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0359202008.SGD","LU0211977185.USD","LU0979878070.USD","LU0289960550.SGD","SG9999001226.SGD","LU0254981946.USD","LU0274383008.USD","LU0348805143.USD","LU0819121731.USD","LU1242518857.USD","LU2097828805.USD","81211","LU0348766576.USD","BK1589","BK1119","LU0588546209.SGD","LU0417516738.SGD","BK1540","LU0320764599.SGD","BK1515","BK1504","IE00BD6J9T35.USD","LU0348767384.USD","LU0516423174.USD","LU0856984785.SGD","LU0214875030.USD","01211","LU0359201612.USD","BK1607","00285","LU1242518931.SGD","BK1522","BK1149","LU1861219969.SGD","LU1868838027.USD","LU0516422440.USD","LU0516422952.EUR","LU1868837722.USD","HYDD.SI","LU2097828631.EUR","LU2097828714.EUR","BYDDY","LU2153592121.USD","002594","LU2360107325.USD","SG9999015945.SGD","BK1509","LU2249611893.SGD","LU0164872284.USD","LU2476274308.USD"],"gpt_icon":1},{"id":"2517937639","title":"歌禮制藥-B(1672.HK)：早期臨牀研發取得突破 GLP1口服藥物值得關注","url":"https://stock-news.laohu8.com/highlight/detail?id=2517937639","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517937639?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 00:00","pubTimestamp":1741104000,"startTime":"0","endTime":"0","summary":"数据显示，前两个列队中ASC30 经安慰剂组校准后分别使体重下降4.2%和6.2%，并且安全性良好。事件公司发布公告，GLP-1R 激动剂ASC30 在美国Ib 期临床试验取得积极结果。ASC30：发布Ib 期多剂量递增研究结果，前两个队列疗效、安全性表现积极ASC30 是一款正在临床研究中的小分子GLP-1R 偏向激动剂，具有独特和差异化特性，使得同一小分子同时适用于皮下注射和口服片剂给药成为可能。安慰剂组体重下降0.1%，ASC30 组经安慰剂校准后的体重下降为6.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305100124a25fcc58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305100124a25fcc58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","BK1515","01477","01672","BK1574"],"gpt_icon":0},{"id":"2516967725","title":"港交所與迅清結算簽署合作備忘錄；比亞迪募集擬435億港元用於海外擴張等丨港交所早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2516967725","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516967725?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 22:46","pubTimestamp":1741099589,"startTime":"0","endTime":"0","summary":"｜2025年3月5日星期三｜NO.1“人形机器人第一股”优必选单日涨超10%3月4日，“人形机器人第一股”优必选（HK09880，股价102.50港元）涨幅达10.45%，成交额20.3亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503043336319523.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503043336319523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0274383008.USD","LU2097828714.EUR","BK1607","LU0516422952.EUR","LU2476274308.USD","LU0823426480.USD","SG9999006514.SGD","LU0289960550.SGD","LU0348805143.USD","002594","LU0214875030.USD","LU0359201612.USD","LU2097828474.EUR","LU1861214812.USD","LU0588546209.SGD","SG9999015978.USD","LU0143863784.USD","SG9999014674.SGD","LU0819123356.HKD","LU2249611893.SGD","LU1868838027.USD","HYDD.SI","SG9999006597.SGD","BK1515","LU0289739343.SGD","81211","LU1808992512.USD","BK1522","LU0320764599.SGD","BK1589","00285","LU0348766576.USD","BK1149","SG9999001226.SGD","LU0449515922.USD","01211","BYDDY","LU0516422366.SGD","LU2097828805.USD","BK1540","BK1580","LU0359202008.SGD","BK1539","LU0449509016.USD","LU0164872284.USD","LU0516423174.USD","LU0417516738.SGD","BK1509","LU0175139822.USD","LU1868837565.USD"],"gpt_icon":1}],"pageSize":16,"totalPage":37,"pageCount":14,"totalSize":585}]}}